Huberman Lab
Huberman Lab

The Science & Treatment of Bipolar Disorder

November 19, 2026

AI Summary

5 min read

Bipolar disorder is often misunderstood as simple mood swings, but the condition carries a 20 to 30 times greater risk of suicide than the general population, and its defining feature—mania—is not a positive high but a maladaptive state that can destroy lives. In this solo episode, Andrew Huberman breaks down the biology, diagnostic criteria, and treatment landscape for bipolar I and bipolar II, with a deep focus on the history and mechanism of lithium, the role of homeostatic plasticity, and why drug therapy is almost always necessary.

The Two Faces of Bipolar Disorder

Bipolar disorder affects about 1% of the population, with typical onset between ages 20 and 25. It is divided into two main types. Bipolar I is defined by manic episodes lasting seven days or more. During these episodes, a person must display at least three of seven symptoms: distractability, impulsivity, grandiosity, flight of ideas, agitation, no sleep (often for a full week without feeling troubled by it), and rapid pressured speech. Crucially, people with bipolar I do not necessarily experience depressive episodes—they may cycle from mania back to baseline.

Continue reading the full summary in the app — free to try.

Read Full Summary →

Free • No credit card required

What you'll learn

  • 1 (01:00) **Introduction to Bipolar Disorder** - Andrew Huberman introduces the topic, defining bipolar disorder as a condition involving maladaptive shifts in mood, energy, and perception, and emphasizing its severity.
  • 2 (15:23) **Prevalence, Diagnosis, and Types of Bipolar Disorder** - Huberman provides key statistics and defines the diagnostic criteria for Bipolar I and Bipolar II, including the symptom clusters of mania.
  • 3 (36:56) **Time Spent in Symptom States and Heritability** - Huberman discusses the percentage of time people with Bipolar I and II spend in manic, depressed, and symptom-free states, and details the high heritability of the disorder.
  • 4 (64:08) **The Discovery of Lithium as a Treatment** - Huberman recounts the fascinating history of how Australian physician John Cade discovered lithium's calming effect on mania in the 1940s.
  • 5 (76:51) **How Lithium Works at the Cellular Level** - Huberman explains the mechanisms of lithium, including its neuroprotective, anti-inflammatory, and neuroplasticity-enhancing effects.
  • 6 (81:52) **Neural Circuits of Bipolar Disorder: Interoception and Top-Down Control** - Huberman describes the two main neural circuit deficits in bipolar disorder: impaired interoception and reduced top-down control of the limbic system.
  • 7 (95:13) **Homeostatic Plasticity: The Mechanism of Lithium and Ketamine** - Huberman introduces the concept of homeostatic plasticity and explains how lithium and ketamine work on opposite ends of this mechanism.

+ Full timestamped outline available in the app

Guests on this episode

Show Notes

The Science & Treatment of Bipolar Disorder

Huberman Lab